NovImmune (Preclinical Human IL-17 mAb) is Buildings and Property in Switzerland that focus on therapeutic antibody business. They cover business area such as immune related disorder, multiple autoimmune disease.
-
Therapeutic Antibody
-
14 Chemin des Aulx
Plan-Les-Ouates
1228 Geneva
Switzerland
Private
immune related disordermultiple autoimmune disease
* We use standard office opening hours in near NovImmune (Preclinical Human IL-17 mAb)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
NovImmune (Preclinical Human IL-17 MAb) is Buildings and Property business from Switzerland that founded in - ( years old in ), NovImmune (Preclinical Human IL-17 mAb) business is focusing on Therapeutic Antibody.
NovImmune (Preclinical Human IL-17 mAb) headquarter office and corporate office address is located in 14 Chemin des Aulx Plan-Les-Ouates 1228 Geneva Switzerland.
NovImmune (Preclinical Human IL-17 mAb) was founded in Switzerland.
In , NovImmune (Preclinical Human IL-17 mAb) is currently focus on therapeutic antibody sector.
Above is snippet of Google Trends for "therapeutic antibody" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with NovImmune (Preclinical Human IL-17 mAb), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
